Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finasteride Extension for Chronic CSC
NCT01227993Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Oct 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of finasteride in Central Serous Chorioretinopathy (CSCR), sponsored by National Eye Institute. Started Oct 2010; status: completed.
02
Drugs
finasteride
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT01227993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227993.